Clinical Trials
296 trialsMultimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
CIRT
Cardiovascular and Interventional Radiological Society of Europe
Standing Position Ultrasonography: Imaging Efficacy in Detecting Liver Diaphragmatic Dome Blind Area Lesions
The First Hospital of Jilin University
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis
Zhongda Hospital
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
Zhongda Hospital
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Shandong Cancer Hospital and Institute
HCC
Anhui Provincial Hospital
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
MAGNUS-HCC
Seoul St. Mary's Hospital
CHANCE2202
Zhongda Hospital
CHANCE2201
Zhongda Hospital
TraveraRTGx
Travera Inc
VOCAL
Imperial College London
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Methodist Health System
Individualized Surgical Guidance in HCC-BDTT
First Affiliated Hospital, Sun Yat-Sen University
SEEK
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC
First Affiliated Hospital, Sun Yat-Sen University
Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients
Benha University
GENDER-HCC-MET
Tongji University
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)
First Hospital of China Medical University
Using Machine Learning to Identify Responders to TACE or HAIC for uHCC
First Affiliated Hospital, Sun Yat-Sen University
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
University of Texas Southwestern Medical Center
EVOLVE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
BORG
Assistance Publique Hopitaux De Marseille
Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
National Cancer Centre, Singapore
BRA-HEP
AstraZeneca
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
ThinkRADIAL
Asan Medical Center
HCC
CHA University
AI Multitask Model for HCC Treatment
Sun Yat-sen University
Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea
GC Cell Corporation
CT Imaging for Guiding PA-TACE for HCC
Zhujiang Hospital
PROACTIF
Boston Scientific Corporation
Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
Tongji Hospital
Effect of Nutritional Indices on the Prognosis of HCC Patients
The Second Affiliated Hospital of Chongqing Medical University
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Thomas Jefferson University
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer
Thomas Jefferson University
Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis
Ain Shams University
BIM-LT
University Hospital, Grenoble
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
SIRT or TACE Plus Lenvatinib and PD-(L)1 Inhibitor in High Burden HCC
Second Affiliated Hospital of Guangzhou Medical University
1003rcr2022_72
Fondazione IRCCS Policlinico San Matteo di Pavia
ABCHCaen
University Hospital, Caen
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Deep Learning Image Reconstruction for Abdominal CT of Hepatocellular Carcinoma Compared With 3-TESLA MRI
Central Hospital, Nancy, France
K-DETEK
Gene Solutions
Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence
IRCCS Azienda Ospedaliero-Universitaria di Bologna